Call us now to speak with Stem Cell Expert: +91 85549 82236 / 001 868 348 2702

About Us

The Institute is founded to explore the true therapeutic benefits of stem cells. This will be accomplished by conducting clinical trials to understand the safety and efficacy of stem cells administration for chronic inflammatory and neurodegenerative diseases. Our ultimate objective is that the data obtained through these studies will help in devising standard clinical protocols to help all patients.

There is very little knowledge on therapeutic benefits of stem cell therapies. Although there are beneficial claims on the use of stem cells, large proportions of such claims are based on anecdotal evidences and patient testimonies. Therefore, there is a substantial lack in scientific or clinical proof. Our team was designed specifically to conduct clinical trials in stem cell therapy. The idea behind building our organization was to further probe the clinical utility and safety of autologous and allogeneic haematopoietic and mesenchymal stem cells, which have proven its safety profile through anecdotal evidences, patient testimonies and Phase 1 Clinical Trials.

Our science originates from clinical acumen of disease mechanistic scientists such as Dr. Bill Brashier, MD; and stem cell scientist Dr. Senthil Thyagarajan, PhD; who have treated over 100 patients since 2013 and have numerous publications in peer reviewed scientific journals.

Our understanding of stem cell therapy is not limited to few scientists, but to a continuous interactive and collaborative process with colleagues and peers globally who are also involved in stem cell research and have been doing ground breaking research in various field of cellular therapies. We share our research experience and discuss their experiences in order to incorporate most recent advances in our clinical trial protocols.

At NOVO Cellular Medicine Institute, our purpose is to be at the forefront of clinical research for stem cell therapy for all epidemiologically relevant chronic inflammatory and degenerative diseases conducted in accordance to the highest international bioethics and clinical practice standards.